Barclays Maintains Overweight on Healthpeak Properties, Lowers Price Target to $32
Portfolio Pulse from jenniferd'souza@benzinga.com
Barclays analyst Steve Valiquette has maintained an Overweight rating on Healthpeak Properties (NYSE:PEAK) but lowered the price target from $33 to $32.

July 25, 2023 | 10:48 am
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Barclays has maintained an Overweight rating on Healthpeak Properties but lowered the price target from $33 to $32.
The news is directly about Healthpeak Properties. Barclays' decision to maintain an Overweight rating indicates a positive outlook for the company. However, the lowering of the price target may create some uncertainty among investors, potentially impacting the stock's short-term performance.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100